Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,352
Total Claims
$1.3M
Drug Cost
466
Beneficiaries
$2,759
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+25%
Opioid rate vs peers
3.2% vs 2.6% avg
+158%
Cost per patient vs peers
$2,759 vs $1,068 avg
+59%
Brand preference vs peers
14.3% vs 9.0% avg
Opioid Prescribing
3.2%
Opioid Rate
301
Opioid Claims
$3,541
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,328 claims · $1.2M
Generic: 7,937 claims · $128K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 110 | $155K |
| Semaglutide | 61 | $89K |
| Apixaban | 71 | $83K |
| Dapagliflozin Propanediol | 64 | $79K |
| Empagliflozin | 64 | $75K |
| Fluticasone/Umeclidin/Vilanter | 76 | $68K |
| Sitagliptin Phosphate | 51 | $63K |
| Tirzepatide | 43 | $54K |
| Rivaroxaban | 39 | $48K |
| Linaclotide | 35 | $41K |
| Budesonide/Formoterol Fumarate | 40 | $37K |
| Mirabegron | 31 | $27K |
| Dulaglutide | 24 | $24K |
| Insulin Detemir | 21 | $23K |
| Budesonide/Glycopyr/Formoterol | 20 | $20K |
Prescribing Profile
Patient Profile
67
Avg Age
65%
Female
1.53
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data